Last reviewed · How we verify
NCT05054907
Using Wearable Device to Improve Quality of Palliative Care
trial in Terminal Cancer in 75 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 23 September 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 30 April 2023 |
| Sites | 2 locations across Taiwan |
Conditions studied
- Terminal Cancer — all drugs for Terminal Cancer →
- End Stage Cancer — all drugs for End Stage Cancer →
Sponsor
National Taiwan University Hospital
Who can join
Adults 20 to 105, any sex, with Terminal Cancer or End Stage Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is going to use wearable devices and smartphones to collect physical data from terminal patients and build a survival predicting model for terminal patients with machine learning. Investigators hypothesize that continuous physical data monitoring could offer a hint to better predictability in end-of-life care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluating the Potential of Machine Learning and Wearable Devices in End-of-Life Care in Predicting 7-Day Death Events Among Patients With Terminal Cancer: Cohort Study.
Liu JH, Shih CY, Huang HL, Peng JK, et al · · 2023 · cited 28× · PMID 37594793 · DOI 10.2196/47366
Verify or expand the search:
- PubMed search for NCT05054907
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Terminal Cancer
Currently open trials in the same condition.
- NCT06018896 — Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer · Phase 2 · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05054907 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 9 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054907.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing